Cellular Origins, Fresenius Kabi Sign Development Agreement for Scalable Automation of Cell and Gene Therapy Manufacturing

Autor: Cellular Origins

Publikováno v: Business Wire (English). 10/16/2024.

Cellular Origins Appoints Geoffrey Hodge as Non-Executive Director

Autor: Cellular Origins

Publikováno v: Business Wire (English). 07/11/2024.

Cellular Origins, a TTP Company, Appoints Peter Crossley as Chief Operating Officer

Autor: Cellular Origins

Publikováno v: Business Wire (English). 01/25/2024.

Cellular Origins Launches Constellation, Its Configurable Robotic Platform to Enable Scalable Manufacture of Advanced Therapies

Autor: Cellular Origins

Publikováno v: Business Wire (English). 05/31/2023.

Supragranular Pyramidal Cells Exhibit Early Metabolic Alterations in the 3xTg-AD Mouse Model of Alzheimer’s Disease

Autor: Piquet, Juliette, Toussay, Xavier, Hepp, Régine, Lerchundi, Rodrigo, Le Douce, Juliette, Faivre, Émilie, Guiot, Elvire, Bonvento, Gilles, Cauli, Bruno

Publikováno v: Frontiers in Cellular Neuroscience
Frontiers in Cellular Neuroscience, Frontiers, 2018, 12, pp.216. ⟨10.3389/fncel.2018.00216⟩
Frontiers in Cellular Neuroscience, Vol 12 (2018)
Frontiers in Cellular Neuroscience, 2018, 12, pp.216. ⟨10.3389/fncel.2018.00216⟩

International audience; The impairment of cerebral glucose utilization is an early and predictive biomarker of Alzheimer's disease (AD) that is likely to contribute to memory and cognition disorders during the progression of the pathology. Yet, the c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e57837c36ae13f7aa762d9088af67f89
https://hal-cea.archives-ouvertes.fr/cea-02158639/document